Log In or Register

Your browser either doesn't support Style Sheets or they are turned off. Click to find out more.
All-in-One Report Demo (NSN: 6505016542274, Part Number: 1402465)
Master Cross Reference Data (MCRD) - alternate part numbers for national stock numbers
NSN
Description
MCRL Information
 
6505016542274

FILGRASTIM INJECTION

INC: 47613
HMIC: P
ESDC:
ENAC:
Cancelled By:
Part # MCRL
Information
CAGE Code
Phone
Fax
Company Name
Address
1402465 ISC: 5
RNVC: 1
RNCC: 5
DAC: 4
Details Available
Details Available
Details Available
Details Available
Details Available
6505NCM162737 ISC: 5
RNVC: 1
RNCC: 5
DAC: 4
Details Available
Details Available
Details Available
Details Available
Details Available
NDC55513-0530-10 ISC: 5
RNVC: 2
RNCC: 3
DAC: 4
Details Available
Details Available
Details Available
Details Available
Details Available
 
 
Technical Characteristics - detailed information such as measurements and material type for national stock numbers
 
NSN
Item Name
Technical Characteristics
6505-016542274

FILGRASTIM INJECTION
MRC Requirements Characteristics
CRLK PRIMARY CONTAINER CONTENT QUANTITY Details Available
CBBL FEATURES PROVIDED Details Available
FEAT SPECIAL FEATURES Details Available
AJCN PROTECTIVE STORAGE FEATURE Details Available
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH Details Available
  
 
Management Data - US Gov't supply management data (costs, storage, etc.)
  NSN
Item Name
Management Data  
  6505-016542274

FILGRASTIM INJECTION
PMIC Criticality ADPE ESDC HMIC DEML
A X 0 P A
S / A SOS AAC QUP UI Unit
Price
SLC CIIC Rep
Code
Mgmt
Ctrl
Phrase
Data
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available
Details Available